The safe use of medicines is of the utmost importance.
To report Adverse reactions and suspected or confirmed pregnancy or fetal exposure, please contact us via one of the following methods:

• E-mail: dsbelgium@bms.com
• Tel. : +32 (0) 2 352 76 11
• Post to: Bristol Myers Squibb, Parc de l’Alliance, Avenue de Finlande 4, 1420 Braine-L’Alleud, Belgium

For Belgium:

Additionally, Healthcare professionals in Belgium are asked to report side effects to the Vigilance Department of the Federal Agency for Medicines and Health Products (FAMHP), preferably via their website www.notifieruneffetindesirable.be.

Alternatively, you can use the “yellow paper sheet” which is available on request from the FAMHP or can be printed from www.fagg.be. The completed yellow form should be sent to the FAMHP via one of the following methods:

• E-mail to: adr@fagg-afmps.be
• Fax: 02 528 40 01
• Post to: AFMPS, Division Vigilance, Avenue Galilée 5/03, 1210 Bruxelles.

For Luxembourg:

Reports of adverse events can be sent to the Center Régional de Pharmacovigilance de Nancy via one of the following methods:

• Email: crpv@chru-nancy.fr
• Tel: (+33) 3 83 65 60 85/87
• Post to: Center Régional de Pharmacovigilance de Nancy, Bâtiment de Biologie Moléculaire et de Biopathologie (BBB), CHRU de Nancy – Hôpitaux de Brabois, Rue du Morvan, 54 511 Vandoeuvre les Nancy Cedex, France.

Or send your report to the Direction de la Santé, Division de la Pharmacie et des Médicaments via one of the following methods:

• Online via the form at: https://guichet.public.lu/fr/entreprises/sectoriel/sante/medecins/notification-effets-indesirables-medicaments.html
• Email: pharmacovigilance@ms.etat.lu
• Tel: (+352) 2 478 5592
• Post to: Direction de la Santé, Division de la Pharmacie et des Médicaments, 20 rue de Bitbourg, L-1273 Luxembourg-Hamm.

Complaints and fight against counterfeiting

If you have any complaints or if you suspect that your medicine has been counterfeited, please email: medicalinfo.belgium@bms.com